Modeling the synergy between HSV-2 and HIV and potential impact of HSV-2 therapy

Mathematical Biosciences

Volumn 245, Issue 2, 2013, Pages 171-187

  Feng, Zhilan ^a,c   Qiu, Zhipeng ^b,c   Sang, Zi ^b   Lorenzo, Christina ^c   Glasser, John ^d  

^a NANJING UNIVERSITY OF INFORMATION SCIENCE AND TECHNOLOGY   (China)

^b NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c PURDUE UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Co infection; Heterogeneity; HIV transmission; HSV 2 therapy; Synergy

Indexed keywords

CO-INFECTIONS; HETEROGENEITY; HIV TRANSMISSION; HSV-2 THERAPY; SYNERGY;

STATISTICS;

MATHEMATICAL TECHNIQUES;

DISEASE PREVALENCE; EPIDEMIOLOGY; HETEROGENEITY; HUMAN IMMUNODEFICIENCY VIRUS; NUMERICAL MODEL; POPULATION DYNAMICS; QUALITATIVE ANALYSIS;

ANTIVIRAL THERAPY; ARTICLE; COMPARTMENT MODEL; EPIDEMIC; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION SENSITIVITY; MIXED INFECTION; POPULATION DYNAMICS; QUALITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SIMULATION; STEADY STATE; VIRUS REPLICATION; VIRUS TRANSMISSION;

HUMAN HERPESVIRUS 2;

CO-INFECTION; HETEROGENEITY; HIV TRANSMISSION; HSV-2 THERAPY; SYNERGY;

ANTIVIRAL AGENTS; BASIC REPRODUCTION NUMBER; COINFECTION; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; DISEASE SUSCEPTIBILITY; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; MALE; MATHEMATICAL CONCEPTS; MODELS, BIOLOGICAL;

EID: 84884144909     PISSN: 00255564     EISSN: 18793134     Source Type: Journal    
DOI: 10.1016/j.mbs.2013.07.003     Document Type: Article

References (36)

1. Cohen M.S., Hellmann N., Levy J.A., Decock K., Lange J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest. 2008, 118:1244.
2. Blower S., Ma L. Calculating the contribution of herpes simplex virus type 2 epidemics to increasing HIV incidence: treatment implications. Clin. Infect. Dis. 2004, 39(Suppl 5):S240.
3. Centers for Disease Control and Prevention, 2012. http://www.cdc.gov/std/herpes/stdfact-herpes.htm.
4. Centers for Disease Control and Prevention, Seroprevalence of herpes simplex virus.
5. Blower S.M., Porco T.C., Darby G. Predicting and preventing the emergence of antiviral drug resistance in HSV-2. Nat. Med. 1998, 4:673.
6. Foss A.M., Vickerman P.T., Chalabi Z., Mayaud P., Alary M., Watts C.H. Dynamics modeling of herpes simplex virus type-2 (HSV-2) transmission: issue in structure uncertainty. Bull. Math. Biol. 2009, 71:720.
7. Freeman E.E., Weiss H.A., Glynn J.R., Cross P.L., Whitworth J.A., Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20:73.
8. Wald A., Link K. Risk of human immunodeficiency virus infection in Herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 2002, 185:45.
9. Sexton J., Garnett G., Rottingen J.-A. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex. Transm. Dis. 2005, 32:351.
10. J.M. Baeten, C. Celum, Herpes simplex virus and HIV-1, 2006,. http://hivinsite.ucsf.edu/InSite?page=kb-05-03-02.
11. Gray R.H., Li X., Wawer M.J., Serwadda D., Sewankambo N.K., Wabwire-Mangen F., Lutalo T., Kiwanuka N., Kigozi G., Nalugoda F., Meehan M.P., Robb M., Quinn T.C. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. J. Infect. Dis. 2004, 189:1209.
12. Schacker T., Zeh J., Hu H., Shaughnessy M., Corey L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J. Infect. Dis. 2002, 186:1718.
13. Foss A.M., Vickerman P.T., Mayaud P., et al. Modeling the interactions between herpes simplex virus type 2 and HIV: implications for the HIV epidemic in southern India. Sex. Transm. Infect. 2011, 87:22.
14. Newton E.A., Kuder J.M. A model of the transmission and control of genital herpes. Sex Transm. Dis. 2000, 27:363.
15. Schinzai R.B. Strategies to control the genital herpes epidemic. Math. Biosci. 1999, 159:113.
16. Blower S.M., Dowlatabadi H. Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int. Stat. Rev. 1994, 62:229.
17. Blower S.M., Aschenbanch A.N., Gershengorn H.B., Kahn J.O. Predicting the unpredictable: transmission of drug-resistant HIV. Nat. Med. 2001, 7:1016.
18. Blower S.M., Gershengorn H.B., Grant R.M. A tale of two futures: HIV and antiviral therapy in San Francisco. Science 2000, 287:650.
19. Mukandavire Z., Garira W. Age and sex structured model for assessing the demographic impact of mother-to child transmission of HIV/AIDS. Bull. Math. Biol. 2007, 69:2061.
20. Mukandavire Z., Garira W. Sex-structured HIV/AIDS model to analyze the effects of condom use with application to Zimbabwe. J. Math. Biol. 2007, 54:669.
21. White R.G., Freeman E.E., Orroth K.K., Bakker R., Weiss H.A., et al. Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa. Sex. Transm. Infect. 2008, 84(Suppl. 2):ii12.
22. Abu-Raddad L.J., Magaret A.S., Celum C., et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008, 3:e2230.
23. Anderson R.M. Transmission dynamics of sexually transmitted infections. Sexually Transmitted Diseases 1999, 25. McGraw-Hill, New York. 3rd ed. K.K. Holmes, P.F. Sparling, P.A. Mardh, S.M. Lemon, W.E. Stamm, P. Piot, J.N. Waserheit (Eds.).
24. Keeling M.J., Eames K.D. Networks and epidemic models. J. R. Soc. Interf. 2005, 2:295.
25. Corey L., Wald A., Patel R., Sacks S.L., Tyring S.K., Warren T., et al. Once-daily valcyclovir to reduce the risk of transmission of genital herpes. New Engl. J. Med. 2004, 350:11.
26. Wald A., Langenberg A.G., Link K., Izu A.E., Ashley R., Warren T., et al. Effect of condoms on reducing the transmission of Herpes simplex virus type-2 from men to women. J. Am. Med. Assoc. 2001, 285:3100.
27. Hethcote H.W. The mathematics of infectious diseases. SIAM Rev. 2000, 42:599.
28. Diekmann O., Heesterbeek J.A.P. Mathematical Epidemiology of Infections Disease: Model Building, Analysis and Interpretation 2000, Wiley, New York.
29. Van Den Driessche P., Watmough J. Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Math. Biosci. 2002, 180:29.
30. Jiang J., Qiu Z., Wu J., Zhu H. Threshold conditions for West Nile virus outbreaks. Bull. Math. Biol. 2009, 71:627.
31. Jiang J., Qiu Z. The complete classification for dynamics in a 9-dimensional West Nile virus model. SIAM J. Appl. Math. 2009, 69:1205.
32. Thieme H.R. Persistence under relaxed point-dissipativity with an application to an epidemic model. SIAM J. Math. Anal. 1993, 24:407.
33. Wang W., Zhao X. An epidemic model in a patchy environment. Math. Biosci. 2004, 190:97.
34. Feng Z., Qiu Z., Sang Z. Global stability of a 9-dimensional HSV-2 epidemic model. Can. Appl. Math. Q. 2011, 19:319.
35. Thieme H.R. Convergence results and a Poincare-Bendixson trichotomy for asymptotically autonomous differential equations. J. Math. Biol. 1992, 30:755.
36. Helton J.C., Johnson J.D., Sallaberry C.J., Storlie C.B. Survey of sampling-based methods for uncertainty and sensitivity analysis. Reliab. Eng. Syst. Saf. 2006, 91(10):1175.